- 3 days ago
Besponsa ‘More Effective’ at Driving Remission for Pediatric B-ALL
Besponsa provides another — and potentially more effective — option outside of traditional chemotherapy for pediatric patients with...
- Apr 16
Researchers find genetic variant contributing to disparities in childhood leukemia risk
Acute lymphoblastic leukemia (ALL), the most common childhood cancer, disproportionately affects children of Hispanic/Latino origin in...
- Feb 14
Advancements in Treating Childhood B Cell Acute Lymphoblastic Leukemia: A Journey Towards Complete Remission
Childhood B cell acute lymphoblastic leukemia (B-ALL), a type of cancer that affects blood and bone marrow, has historically been a...
- Feb 5
RNA sequencing analysis may hold the key to more accurate diagnosis and targeted treatment of pediatric B-acute lymphoblastic leukemia
Pilot study by Children’s Hospital Los Angeles and City of Hope proposes a promising global, clinically applicable genomic assay for the...
- Jan 4
Could the gut microbiome play a key role in preventing childhood leukaemia?
Now a team of researchers at the Institute of Cancer Research (ICR) in London suggests that the microbiome could play an important role...
- Dec 8, 2023
Study shows potential of new treatment strategies for most common childhood cancer
UBC Faculty of Medicine researchers at the BC Children’s Hospital Research Institute (BCCHR) have made a key discovery about how...
- Oct 31, 2023
Cranial Radiotherapy Predisposes Pediatric Cancer Survivors to Hypothyroidism
Hypothyroidism and hypogonadism are likely among cranial radiotherapy-treated survivors of childhood-onset acute lymphoblastic leukemia...
- Oct 30, 2023
Examining outcomes in children with Down syndrome and acute lymphoblastic leukemia
Children with Down syndrome have an increased risk of developing acute lymphoblastic leukemia (ALL) and experience higher rates of...